CEO and GP
Nexus Neurotech Ventures
Jordi is the co-founder, General Partner and CEO of Nexus Neurotech Ventures, a Venture Capital firm devoted to invest in
companies with a deep commitment to developing technologies to help those with neurodegenerative, neuropsychiatric, and neurodevelopmental disorders.
Prior to this role, Jordi served as President, Medical Devices at Verily Life Sciences (Alphabet’s healthcare company, formerly Google Life Sciences), where he was responsible for leading Verily’s Medical Devices business, combining hardware, software, and AI/ML to create differentiated and clinically validated solutions for Verily’s clinical research products and healthcare products, as well as external research and commercial partnerships and joint ventures.
Before joining Verily, Jordi spent twelve years at Boston Scientific, ultimately serving in the role of Director of R&D, Neuromodulation, bringing to market various generations of implantable products for the Chronic Pain (Spinal Cord Stimulator) as well as the Movement Disorders/Parkinson’s Disease (Deep Brain Stimulator) franchises. Jordi started his career at Advanced Bionics where he was a key contributor on advanced technology for neuromodulation. Jordi holds 200+ worldwide patents with 60+ distinct patent families and earned a Ph.D., M.S., and B.S. in Electrical Engineering and a B.S. in Physics from the Universitat Autònoma de Barcelona.
Funding Outlook for Neuromodulation Startups
Thursday, January 22, 2026
9:15 AM - 10:00 AM PST